OBIO vs PLTR · rev $198.0K vs P/E 584, rev $3.57B
Orchestra BioMed Holdings Inc. (OBIO) versus Palantir Technologies Inc. Class A Common Stock (PLTR) — a side-by-side from cached financials, not a winner call.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.
Latest reported PLTR revenue for 2026-06-30 was $3.57B. Net income was $1.93B. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
OBIO currently screens at market cap $231.7M. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Not investment advice. Open the OBIO and PLTR stock pages for the full models.
Not investment advice.